The use of vaccines as an adjuvant treatment following surgery seems ideal since removal of the tumor abrogates the tumor-mediated immunosuppression and minimizes the number of post-operative tumor cells and therefore the chance for the survival of MHC-negative clones. The gene discussed is HLA-C; the disease is neoplasm.